A Study of Minirin Melt in Patients With Nocturia
- Conditions
- Nocturia
- Registration Number
- NCT01222598
- Lead Sponsor
- Ferring Pharmaceuticals
- Brief Summary
This is a confirmation of safety profile for Minirin Melt in clinical practice.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 588
- patients suffering from Nocturia
- habitual or psychogenic polydipsia
- known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics
- moderate and severe renal insufficiency
- know hyponatremia
- syndrome of inappropriate ADH secretion
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of participants with adverse events 12 months
- Secondary Outcome Measures
Name Time Method Number of participants with nocturnal voiding 12 months Number of participants with adverse events 12 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (28)
Private Ambulance
🇨🇿Třebíč, Czech Republic
Trauma Hospital in Brno
🇨🇿Brno, Czech Republic
Urocentrum
🇨🇿Brno, Czech Republic
Uromeda, s.r.o.
🇨🇿Brno, Czech Republic
Hospital Dečín
🇨🇿Děčín, Czech Republic
University Hospital Hradec Králové
🇨🇿Hradec Králové, Czech Republic
Hospital Jablonec nad Nisou
🇨🇿Jablonec nad Nisou, Czech Republic
Hospital Jihlava
🇨🇿Jihlava, Czech Republic
Hospital Kroměříž
🇨🇿Kroměříž, Czech Republic
Polyclinic Kuřim
🇨🇿Kuřim, Czech Republic
Scroll for more (18 remaining)Private Ambulance🇨🇿Třebíč, Czech Republic